Elissa A. Buchanan

PRACTICE AREAS

Antitrust
Intellectual Property

ADMISSIONS

State of California

EDUCATION

University of San Francisco School of Law, J.D.

Mills College, B.A., French Studies

LANGUAGES

French (conversational reading and speaking)

Elissa Buchanan’s legal expertise is in antitrust, construction defect, and corporate securities and shareholder litigation.

Representative matters include:

  • Capacitors Price-Fixing Antitrust Litigation: The Firm is Sole Lead Counsel in a class action lawsuit alleging that global capacitor manufacturers conspired to fix prices, forcing direct purchasers to pay more. Class is certified and trial is set for 2020. Initial settlements in the case total $219.5 million;
  • EpiPen Marketing, Sales Practices, and Antitrust Litigation: The Firm is on the Plaintiffs’ Steering Committee leading a class action alleging that Pfizer and Mylan—manufacturer and distributor of the epinephrine autoinjector EpiPen, respectively—have unlawfully created and abused a monopoly for the life-saving product. Plaintiffs seek to recover damages and overpayments from at least 2009 through the present, as well as injunctive relief under the federal antitrust laws and various state consumer protection and antitrust laws;
  • Opana Antitrust Litigation: The Firm represents a Plaintiff in a proposed class action brought by California indirect purchasers against brand and generic manufacturers of Opana ER. Plaintiff alleges that Defendants Endo Pharmaceuticals Inc. and Impax Laboratories entered an illegal pay-for-delay or reverse payment agreement whereby Endo provided Impax over $100 million in cash, as well as other valuable consideration, in exchange for Impax’s promise to keep generic versions of Opana ER off the market. Plaintiff alleges this prevented generic competition and resulted in higher prices. In addition, Plaintiff alleges that Endo attempted an unlawful product hop in an effort to further raise prices to consumers;
  • Restasis Antitrust Litigation: The Firm represents the Self-Insured Schools of California in a class action lawsuit against Allergan, Inc. The suit alleges that Allergan participated in a scheme to delay generic competition to Allergan’s blockbuster Restasis drug and extended its monopoly in the Restasis market through a series of fraudulent and anticompetitive acts. On March 22, 2018, Judge Gershon appointed the Firm as Interim Co-Lead Counsel on behalf of End-Purchaser Plaintiffs; and
  • UFC Antitrust Litigation: The Firm is Co-Lead Counsel for current and former Elite Professional Mixed Martial Arts (MMA) Fighters in a class action lawsuit against Ultimate Fighting Championship (UFC), alleging that UFC illegally acquired and maintained a monopoly and monopsony power over Elite Professional MMA fighters, and used that power to suppress their compensation.

Prior to joining the Firm, Elissa worked as a contract attorney on construction defect litigation and antitrust and personal injury class actions. During law school, she interned at California Lawyers for the Arts, where she worked with artist clients to find solutions to copyright and trademark issues. She also was a technical editor for the Journal of Law and Social Justice and volunteered for Law in Motion, a program that provides opportunities for the law school community to reflect on issues of social justice and access to equal justice through various activities and events.

Elissa is a member of the American Bar Association.